References
- Barker AF. Bronchiectasis. N Engl J Med 2002; 346: 1383–1393
- Wilson R, Boyton R. Bronchiectasis. Encyclopedia of respiratory medicine, GJ Laurent, SD Shapiro. Elsevier, OxfordUK 2006; 259–268
- Hansell D. Bronchiectasis. Radiol Clin North Am 1998; 36: 107–28
- Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol 2000; 29: 182–187
- Callahan CW. Bronchiectasis: abated or aborted?. Respiration 2005; 72: 225–226
- Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis “too high” for a developed country. Arch Dis Child 2005; 90: 737–740
- Chang AB, Grimwood K, Mulholland EK, et al. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 2002; 177: 200–204
- Clark NS. Bronchiectasis in childhood. Br Med J 1963; 1: 80–88
- Sayajakangas O, Keistinen T, Tuuponen T, et al. Evaluation of the incidence and age distribution of bronchiectasis from the Finnish Hospital Discharge Register. Cent Eur J Public Health 1998; 6: 235–237
- Morrissey BM, Harper RW. Bronchiectasis: sex and gender considerations. Clin Chest Med 2004; 25: 361–372
- Cohen M, Sahn SA. Bronchiectasis in systemic disease. Chest 1999; 116: 1063–1074
- Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation of causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000; 162: 1277–1284
- Wickremasinghe M, Ozerovitch LJ, Davies G, et al. Non-tuberculosis mycobecteria in patients with bronchiectasis. Thorax 2005; 60: 1045–1051
- Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Eng J Med 1996; 335: 1941–1949
- Kunst H, Wickremasinghe M, Wells A, et al. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 2006; 28: 352–457
- Kelleher P, Goodsall A, Mulgirigama A, et al. Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis. Eur Respir J 2006; 27: 1307–1310
- Boyton R, Reynolds C, Wahid F, et al. IFN γ and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 2006; 68: 325–330
- Lopez-Maderuelo D, Arnalich F, Serantes R, et al. Interferon-γ and IL-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 167: 970–975
- Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182: 190–200
- Boyton RJ, Smith J, Jones M, et al. Human leucocyte antigen (HLA) class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clin Exp Immunol 2007; 149: 1–8
- Gadola SD, Mains-Teissererc HT, Trowsdale J, et al. TAP deficiency syndrome. Clin Exp Immunol 2000; 121: 173–178
- Boyton RJ, Smith J, Ward R, et al. HLA-C and killer cell immunoglobulin-like receptor (KIR) genes in susceptibility to bronchiectasis. Am J Respir Crit Care Med 2006; 176: 327–333
- Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 2007; 149: 1–8